共 50 条
- [41] Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis Neurotherapeutics, 2017, 14 : 835 - 841
- [47] Serum uric acid levels in multiple sclerosis patients inversely correlate with disability Neurological Sciences, 2011, 32 : 347 - 350
- [50] Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosis MED, 2023, 4 (06): : 361 - +